Updated Jul 16, 2026
RIEDEL NORBERT G has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $656K.
Norbert G. Riedel is a corporate executive known for his role as a Director at Jazz Pharmaceuticals plc, a biopharmaceutical company focused on treatments for sleep disorders and oncology. He has a background in the pharmaceutical industry, contributing to the development and commercialization of various medical products.
| Role | Director |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-04-22 | ETON | Eton Pharmaceuticals, Inc. | M — Option exercise | 19.7K | $8.61 | $169K |
| 2026-04-22 | ETON | Eton Pharmaceuticals, Inc. | M — Option exercise | 12.5K | $7.31 | $91K |
| 2026-03-02 | JAZZ | Jazz Pharmaceuticals plc | S — Open-market sale | 3.4K | $192.00 | $656K |
| 2026-03-02 | JAZZ | Jazz Pharmaceuticals plc | M — Option exercise | 3.4K | $138.08 | $472K |
| 2026-02-05 | ETON | Eton Pharmaceuticals, Inc. | J — Other acquisition / disposition | 30.0K | $4.42 | $133K |
| 2025-08-07 | JAZZ | Jazz Pharmaceuticals plc | F — Tax withholding / forfeiture | 1.8K | $111.25 | $201K |
| 2025-08-07 | JAZZ | Jazz Pharmaceuticals plc | A — Grant or award | 3.5K | $0.00 |
Norbert G. Riedel is a corporate executive known for his role as a Director at Jazz Pharmaceuticals plc, a biopharmaceutical company focused on treatments for sleep disorders and oncology. He has a background in the pharmaceutical industry, contributing to the development and commercialization of various medical products.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 1 open-market sales ($656K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live RIEDEL NORBERT G profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.